Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cardiovascular disease

Can Rheumatologists Prescribe Exercise as Medicine?

Larry Beresford  |  January 19, 2018

SAN DIEGO—Exercise, within limits imposed by an individual’s circumstances, is an almost universally beneficial medical therapy. In fact, Teresa J. Brady, PhD, senior behavioral scientist with the federal Centers for Disease Control and Prevention’s Arthritis Program, labeled it “medicine” in a session on exercise at the 2017 ACR/ARHP Annual Meeting Nov. 3–8. Dr. Brady asked whether…

Filed under:ConditionsMeeting Reports Tagged with:ACR/ARHP Annual Meetingpatient carerheumatologistTreatment

The Diagnosis: How to Advise Newly Diagnosed RA Patients

Karen Appold  |  January 8, 2018

Receiving an RA diagnosis may be emotional and difficult for patients. By engaging the patient in learning about the disease and its treatment options, as well as cultivating a communicative relationship, rheumatologists can truly help a patient take control of their health…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Diagnosisearly diagnosispatient carepatient educationRheumatoid Arthritis (RA)

A History of the Science, Treatment of Rheumatologic Illnesses from Gold to Gene Therapy

Simon M. Helfgott, MD  |  December 17, 2017

Mysterious Ways The juxtaposition of the old and the new was readily evident that busy Wednesday morning. My first patient, a 94-year-old gentleman, Hal, arrived with a precise request. His rheumatologist for the past 40 years had just retired, and he was searching for a doctor with expertise in the use of gold sodium aurothioglucose,…

Filed under:ConditionsOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:American College of Rheumatology (ACR)American Rheumatism AssociationArthritisautoimmune mediated diseasebioinformaticsC-reactive proteinClinicalcorticosteroid drugsDiagnosisgenomicsHistoryimmune-suppressive therapiesinflammationknowledgemedicalpatient careResearchRheumatic Diseaserheumatologysciencetranslational researchTreatment

Year in Review: Expert Covers 2017’s Key Clinical Findings

Thomas R. Collins  |  November 20, 2017

In a Year in Review session at the 2017 ACR/ARHP Annual Meeting, Daniel Solomon, MD, MPH, highlighted the latest and most intriguing aspects of clinical research on rheumatic diseases from 2017. His discussion touched on medical therapy, genetics, the effects of bariatric surgery and diet, cancer risk and more…

Filed under:Axial SpondyloarthritisConditionsGout and Crystalline ArthritisMeeting ReportsResearch Rheum Tagged with:2017 ACR/ARHP Annual MeetingACR/ARHP Annual MeetingAnkylosing SpondylitiscardiovascularDASH dietGoutjuvenile idiopathic arthritis (JIA)Knee Osteoarthritis (OA)secukinumab

Physical Activity, Exercise Can Benefit Patients with RA

August Floden, PT, MS  |  November 9, 2017

While medical advances in rheumatoid arthritis (RA) have led to improvements in disease control and quality of life for patients worldwide, the rate for stable remission remains low.1 Management of RA symptoms is traditionally accomplished through a combination of medications and nonpharmacological interventions.2 This approach can prevent the development of secondary adverse health outcomes. Two…

Filed under:ConditionsPractice SupportRheumatoid Arthritis Tagged with:ExerciseMedicationpatient carephysical activityPhysical TherapyRARheumatoid arthritisrheumatologistrheumatology

The ACR Rheumatology Research Workshop Designed to Promote Collaboration, Mentoring Among Investigators

Iris Navarro-Milan, MD, & Jeffrey Sparks, MD, MMSc  |  October 16, 2017

The ACR Rheumatology Research Workshop (RRW) is a two-day meeting designed to promote interactions between early and established investigators to foster collaboration and facilitate career mentoring. The RRW is targeted to rheumatology fellows, junior faculty, medical/graduate students, and residents interested in learning more about how to succeed in a research career for rheumatology. RRW is…

Filed under:Career DevelopmentFrom the CollegeProfessional TopicsResearch Rheum Tagged with:AC&RACR Rheumatology Research WorkshopAmerican College of Rheumatology (ACR)CareercollaborationfacultyFellowsinvestigatormedical studentsMentorResearchrheumatologist

Ibuprofen More Likely to Raise BP than Naproxen or Celecoxib

Anne Harding  |  September 12, 2017

NEW YORK (Reuters Health)—Ibuprofen boosts blood pressure (BP) more than naproxen or celecoxib in patients who take non-steroidal anti-inflammatory drugs (NSAIDs) to treat arthritis, according to a new substudy from the PRECISION trial. “These drugs are different with regard to BP, and ibuprofen is the worst,” Dr. Frank Ruschitzka of University Hospital Zurich in Switzerland,…

Filed under:AnalgesicsDrug Updates Tagged with:Arthritisblood pressurecelecoxib (Elyxyb)IbuprofennaproxenNonsteroidal anti-inflammatory drugs (NSAIDs)NSAIDsPain

Anti-TNF-Alpha Agents May Improve Endothelial Function Patients with RA

Lara C. Pullen, PhD  |  August 7, 2017

A systematic review has found that anti-tumor necrosis factor alpha treatment may improve endothelial function in RA patients. Despite the heterogeneity of the included studies, a random-effects model showed a significant improvement in endothelial function in this patient population after receiving infliximab, adalimumab or etanercept…

Filed under:ConditionsRheumatoid Arthritis Tagged with:adalimumabAnti-TNFendothelial cellsetanerceptinfliximabRheumatoid Arthritis (RA)

Progress Made During HOD Annual Meeting

Gary L. Bryant, MD, FACR, FACP  |  July 24, 2017

The AMA House of Delegates (HOD) met in Chicago for its annual meeting June 9–14. More than 530 HOD members were present, with several hundred AMA and association staff and guests. As I am sure you have noted from past issues of ACR@Work, the ACR is in its five-year membership review. The ACR must be…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AMA annual meetingAMA House of Delegates (HOD)AMA membership

Advancements in Diagnosis, Treatment for Antiphospholipid Syndrome

Lara C. Pullen, PhD  |  July 14, 2017

CHICAGO—Doruk Erkan, MD, MPH, a rheumatologist at the Hospital for Special Surgery and Weill Cornell Medicine in New York City, described recent developments in the field of antiphospholipid syndrome (APS) to the rheumatologists gathered for the ACR’s State-of-the-Art Clinical Symposium in April. He introduced APS as a “field with limited data and lots of controversies,” although,…

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)Antiphospholipid Antibody Syndrome (APS)Classification CriteriaDiagnosisHughes SyndromepreventionResearchrheumatologyriskthrombosisTreatment

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 64
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences